Review Article
Androgen receptor in breast cancer and its clinical implication
Translational Breast Cancer Research
2023;
4:
30
(31 October 2023)
Review Article
A clinical perspective on oncoplastic breast conserving surgery
Translational Breast Cancer Research
2023;
4:
29
(31 October 2023)
Review Article
New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment
Translational Breast Cancer Research
2023;
4:
28
(31 October 2023)
Original Article
Self-detection remains a primary means of breast cancer detection in Beijing, China
Translational Breast Cancer Research
2023;
4:
27
(31 October 2023)
Original Article
Interaction of de novo cholesterol biosynthesis and Hippo signaling pathway in ductal carcinoma in situ (DCIS)—comparison with the corresponding normal breast epithelium
Translational Breast Cancer Research
2023;
4:
26
(31 October 2023)
Case Report
Individualize management for advanced breast cancer with pyrotinib-based anti-HER2 therapy: a case report
Translational Breast Cancer Research
2023;
4:
25
(31 July 2023)
Mini-Review
Reporting breast density on chest computed tomography
Translational Breast Cancer Research
2023;
4:
24
(31 July 2023)
Review Article
Translating new breast ultrasound techniques into clinical practice: evaluating their intended uses and describing other unexpected uses for them
Translational Breast Cancer Research
2023;
4:
23
(31 July 2023)
Review Article
Features and applications of Ehrlich tumor model in cancer studies: a literature review
Translational Breast Cancer Research
2023;
4:
22
(31 July 2023)
Review Article
Biomarkers derived from CmP signal network in triple negative breast cancers
Translational Breast Cancer Research
2023;
4:
21
(31 July 2023)
Review Article
Types and progress of clinical trial design for breast cancer: a narrative review
Translational Breast Cancer Research
2023;
4:
20
(31 July 2023)
Original Article
Real-world efficacy of postoperative radiotherapy with a moderate dose-escalation for phyllodes tumors of the breast
Translational Breast Cancer Research
2023;
4:
19
(31 July 2023)
Original Article
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer: a long-term safety and overall survival update from the randomised, double-blind, placebo-controlled, phase 3 trial
Translational Breast Cancer Research
2023;
4:
18
(31 July 2023)
Editorial Commentary
Updates on the preoperative immunotherapy for triple-negative breast cancer
Translational Breast Cancer Research
2023;
4:
17
(30 April 2023)
Review Article
Narrative review on the role of immunotherapy in early triple negative breast cancer: unveiling opportunities and overcoming challenges
Translational Breast Cancer Research
2023;
4:
16
(30 April 2023)
Review Article
HER2-low breast cancer: insights on pathological testing
Translational Breast Cancer Research
2023;
4:
15
(30 April 2023)
Review Article
Breast biopsy techniques in a global setting—clinical practice review
Translational Breast Cancer Research
2023;
4:
14
(30 April 2023)
Review Article
Key points of anti-tumor treatment in breast cancer patients with SARS-CoV-2 infection
Translational Breast Cancer Research
2023;
4:
13
(30 April 2023)
Review Article
The association between perioperative opioids and breast cancer recurrence: a narrative review of the literature
Translational Breast Cancer Research
2023;
4:
12
(30 April 2023)
Original Article
Antibody-drug conjugate monotherapy refines the oncological efficacy as compared to therapy of physicians’ choices in advanced breast cancers: a systematic review and meta-analysis
Translational Breast Cancer Research
2023;
4:
11
(30 April 2023)
Original Article
Efficacy and safety of abemaciclib-based therapy versus tucidinostat-based therapy after progression on palbociclib in patients with HR+HER2− metastatic breast cancer
Translational Breast Cancer Research
2023;
4:
10
(30 April 2023)
Editorial Commentary
Advances of HER2 testing for women with breast cancer
Translational Breast Cancer Research
2023;
4:
9
(31 January 2023)
Letter to the Editor
Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ER−PR+HER2−) breast cancer
Translational Breast Cancer Research
2023;
4:
8
(31 January 2023)
Review Article
Breast cancer gene expression signatures: development and clinical significance—a narrative review
Translational Breast Cancer Research
2023;
4:
7
(31 January 2023)
Review Article
Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer
Translational Breast Cancer Research
2023;
4:
6
(31 January 2023)